All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 4 of 206 pages ‹ First < 2 3 4 5 6 > Last ›
HSL19496
O'Donoghue N
Pharmacies face advertising investigations
Pharmacy News 2011 Apr 19
http://www.pharmacynews.com.au/news/pharmacies-face-advertising-investigations
HSL19500
Caruana CM
Future pharma: Pharma’s new high-tech toolkit
eyeforpharma.com 2011 Apr 19
http://web.archive.org/web/20110719014333/http://social.eyeforpharma.com/story/future-pharma-pharma%E2%80%99s-new-high-tech-toolkit
HSL19501
Hendel J
Future pharma: What near field communication (NFC) means for pharma
eyeforpharma.com 2011 Apr 19
http://social.eyeforpharma.com/story/future-pharma-what-near-field-communication-nfc-means-pharma
HSL19502
Tolve A
Future pharma: Making games work for pharma
eyeforpharma.com 2011 Apr 19
http://social.eyeforpharma.com/story/future-pharma-making-games-work-pharma
HSL19553
Kaplan RM, Babad YM
Balancing influence between actors in healthcare decision making
BMC Health Services Research 2011 04 19;11:(85):
http://www.biomedcentral.com/1472-6963/11/85/abstract
HSL19732
Ricardo Cardoso P
MED & CINE - Dr. Paulo Ricardo Cardoso: Influência da Indústria Farmacêutica sobre os Médicos
Museu de História da Medicina 2011 Apr 180
http://www.youtube.com/watch?v=Ap1v3XD_69M&feature=youtu.be
HSL19495
Santana S, Lausen B, Bujnowska-Fedak M, Chronaki CE, Prokosch H-U, Wynn R
Informed citizen and empowered citizen in health: results from an European survey
BMC Family Practice 2011 Apr 16;12:(20):
http://www.biomedcentral.com/1471-2296/12/20/abstract
HSL19493
Rola farmaceuty w marketingu
PolishPharma 2011 Apr 12
http://polishpharma.com/rola-farmaceuty-w-marketingu/0,-a7,1
HSL19559
Boniello K
'Face'-off in Prozac ad lawsuit
New York Post 2011 Apr 10
http://www.nypost.com/p/news/local/manhattan/face_off_in_prozac_ad_lawsuit_DjgkvxPe8CLJnO1NfX7V7M
HSL19503
Wright D
Highlights from SFE Europe 2011
eyeforpharma.com 2011 Apr 8
http://social.eyeforpharma.com/blogs/david-wright/highlights-sfe-europe-2011
HSL19504
Sansom C
Personalized medicine: Lesson for Oncology
eyeforpharma.com 2011 Apr 8
http://social.eyeforpharma.com/blogs/clare-sansom/personalized-medicine-lesson-oncology
HSL19488
Silverman E
Should Social Media Shackles Come Off Pharma?
Pharmalot 2011 Apr 7
http://www.pharmalot.com/2011/04/should-social-media-shackles-come-off-pharma/
HSL19489
Silverman E
Antidepressants, Breast Cancer & Industry Studies
Pharmalot 2011 Apr 7
http://www.pharmalot.com/2011/04/antidepressants-breast-cancer-industry-studies/
HSL19490
Silverman E
Did Drugmakers Violate India’s Patent Laws?
Pharmalot 2011 Apr 7
http://www.pharmalot.com/2011/04/did-drugmakers-violate-indias-patent-laws/
HSL19491
Mukherjee R
Drug MNCs violating patent law?
The Times of India 2011 Apr 7
http://articles.timesofindia.indiatimes.com/2011-04-07/india-business/29392126_1_compulsory-licensing-patent-act-patent-office
HSL19480
Silverman E
Whistleblower Lawsuits And Off-Label Marketing
Pharmalot 2011 Apr 6
http://www.pharmalot.com/2011/04/whistleblower-lawsuits-and-off-label-marketing/
HSL19481
Edwards J
Why Do Bloomberg and AP Want to Look at Your Medical Records?
BNet 2011 Apr 6
http://www.bnet.com/blog/drug-business/why-do-bloomberg-and-ap-want-to-look-at-your-medical-records/7849
HSL19472
Thacker P
Ghostwriting controversy haunting the American Psychiatric Association
Project On Government Insight 2011 Apr 5
http://pogoblog.typepad.com/pogo/2011/04/ghostwriting-controversy-haunting-the-american-psychiatric-association.html
HSL19473
Thacker P
American Psychiatric Association Spooked about Ghostwriting
Project On Government Insight 2011 Apr 5
http://pogoblog.typepad.com/pogo/2011/04/american-psychiatric-association-spooked-about-ghostwriting.html
HSL19474
Carroll B
Who You Gonna Believe?
Health Care Renewal Blog 2011 Apr 5
http://hcrenewal.blogspot.com/2011/04/who-you-gonna-believe.html
HSL19476
Carlat D
Like a Bad Penny, the Nemeroff/Schatzberg 'Textbook' Problem Returns
The Carlat Psychaitry Blog 2011 Apr 5
http://carlatpsychiatry.blogspot.com/
HSL19477
Silverman E
American Psychiatric Association And Ghostwriting
Pharmalot 2011 Apr 5
http://www.pharmalot.com/2011/04/american-psychiatric-association-and-ghostwriting/#comment-615263
HSL19479
Kesselheim AS, Mello MM, Studdert DM
Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints
PLoS Med 2011 Apr 5;
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371% 2Fjournal.pmed.1000431
HSL19482
Mack J
Brits Beat FDA & PhRMA: Issue Social Media Guidance for Pharma. This BI Tweet May Not Pass Muster.
Pharma Marketing Blog 2011 Apr 5
http://pharmamkting.blogspot.com/2011/04/brits-beat-fda-phrma-issue-social-media.html
HSL19483
Dyer C
New code requires doctors to disclose all links with drug industry
BMJ 2011 Apr 5;342:
http://www.bmj.com/content/342/bmj.d2188.extract
HSL19475
Bass A
A tale of censorship and secrecy starring the American Psychiatric Association
Alison Bass 2011 Apr 4
http://alison-bass.blogspot.com/2011/04/tale-of-censorship-and-secrecy-starring.html
HSL19484
Silverman E
Novartis, Gleevec And A Patent Dispute In India
Pharmalot 2011 Apr 4
http://www.pharmalot.com/2011/04/novartis-gleevec-and-a-patent-dispute-in-india/
HSL19485
Silverman E
University Researchers & The Spread Of Pain Meds
Pharmalot 2011 Apr 4
http://www.pharmalot.com/2011/04/university-researchers-the-spread-of-pain-meds/
HSL19478
Zielinska E
Medical posters as art
The Scientist 2011 Apr 1
http://www.the-scientist.com/news/display/58099/
HSL19486
Patient Groups, Former HHS Secretaries, U.S. Chamber of Commerce, and More Than 50 Key Healthcare Stakeholders and Researchers Urge Supreme Court to Reject Three State Laws Outlawing Commercial Use of Prescription Data
Pharma Live 2011 Apr 1
http://pharmalive.com/news/index.cfm?articleid=771932
HSL19427
Shrank WH, Liberman JN, Fischer MA, Avorn J, Kilabuk E, Chang A, Kesselheim AS, Brennan TA, Choudhry NK
The consequences of requesting 'dispense as written'.
Am J Med 2011 Apr;124:(4):309-17
http://www.nelm.nhs.uk/en/NeLM-Area/Evidence/Medicines-Management/References/2011---March/29/The-consequences-of-requesting-Dispense-as-written/
HSL19494
Stuckler D, Basu S, McKee M
Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed?
PLoS Med 2011 Apr;8:(4):
http://www.plosmedicine.org/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pmed.1001020&representation=PDF
HSL19554
The World Medicines Situation Report 2011
World Health Organisation 2011 Apr
http://www.who.int/medicines/areas/policy/world_medicines_situation/en/index.html
HSL19558
The World Medicines Situation Report 2011
World Health Organisation 2011 Apr
http://www.who.int/medicines/areas/policy/world_medicines_situation/en/index.html
HSL19467
Wells WA, Brooks A
Adoption of New Health Products in Low and Middle Income Settings: How Product Development Partnerships Can Support Country Decision Making
Health Research Policy and Systems 2011 Mar 31;9:(15):
http://www.health-policy-systems.com/content/9/1/15
HSL19462
New Research Shows MDs Prefer a Mix of Digital, Face-to-Face Marketing
Pharma Live 2011 Mar 31
http://pharmalive.com/news/index.cfm?articleID=771699
HSL19463
Silverman E
What Doctors Do With Their Smartphones
Pharmalot 2011 Mar 31
http://www.pharmalot.com/2011/03/what-doctors-do-with-their-smartphones-2/
HSL19460
Iskowitz M
GSK paid $57 mil. to doctors for speaking and advising in '10
Medical Marketing & Media 2011 Mar 31
http://www.mmm-online.com/gsk-paid-57-mil-to-doctors-for-speaking-and-advising-in-10/article/199663/
HSL19469
Lai NM, Teng CL, Lee ML
Interpreting systematic reviews: are we ready to make our own conclusions?: A cross-sectional study
BMC Medicine 2011 Mar 30;9:(30):
http://www.biomedcentral.com/1741-7015/9/30/abstract
HSL19468
Tricco AC, Straus SE, Moher D
How can we improve the interpretation of systematic reviews?
BMC Medicine 2011 Mar 30;9:(31):
http://www.biomedcentral.com/1741-7015/9/31/abstract
HSL19466
Insider
Novo Nordisk, Eli Lilly, Grünenthal and Napp named in advertisements for breaches of the UK ABPI Code of Practice
Pharma Gossip 2011 Mar 30
http://pharmagossip.blogspot.com/2011/03/novo-nordisk-eli-lilly-grunenthal-and.html
HSL19461
Loftus P
Merck Paid $20.4 Million in Speaking Fees to U.S. Doctors
Market Watch 2011 Mar 30
http://www.marketwatch.com/story/merck-paid-204-million-in-speaking-fees-to-us-doctors-2011-03-30
HSL19457
Taylor L
EU consults on drug pricing/reimbursement decisions
Pharma Times 2011 Mar 30
http://www.pharmatimes.com/Article/11-03-30/EU_consults_on_drug_pricing_reimbursement_decisions.aspx
HSL19453
Schwartz M
FDA again delays promised social media guidance
Medical Marketing & Media 2011 Mar 30
http://www.mmm-online.com/fda-again-delays-promised-social-media-guidance/article/199595/
HSL19452
Avorn J.
Teaching Clinicians about Drugs — 50 Years Later, Whose Job Is It?
NEJM 2011 Mar 30;
http://healthpolicyandreform.nejm.org/?p=14034
HSL19458
Pfizer Collaboration With Apple/FDA: A Strategic Shift to Scientific Content in Marketing
Seeking Alpha 2011 Mar 30
http://seekingalpha.com/article/261036-pfizer-collaboration-with-apple-fda-a-strategic-shift-to-scientific-content-in-marketing
HSL19487
Silverman E
Novo Nordisk Reprimanded For Poor Management
Pharmalot 2011 Mar 30
http://www.pharmalot.com/2011/03/novo-nordisk-reprimanded-for-poor-management/
HSL19456
Silverman E
Conflicts Of Interest & Treatment Guideline Panels
Pharmalot 2011 Mar 29
http://www.pharmalot.com/2011/03/conflicts-of-interest-treatment-guideline-panels/
HSL19455
Wilson D
Study Finds Conflicts Among Panels’ Doctors
The New York Times 2011 Mar 29
http://www.nytimes.com/2011/03/29/health/29ethics.html?_r=1
HSL19450
Kirchgaessner S
Big Pharma faces challenge on drug prices
The Finanical Times 2011 Mar 29
http://www.ft.com/cms/s/0/aadf4ef4-5a2d-11e0-86d3-00144feab49a.html
HSL19434
Arnold M
Docs value details, says PhRMA survey
Medical Marketing & Media 2011 Mar 29
http://www.mmm-online.com/docs-value-details-says-phrma-survey/article/199481/
HSL19435
Silverman E
Drugmakers Cannot Be Sued For Overcharging
Pharmalot 2011 Mar 29
http://www.pharmalot.com/2011/03/drugmakers-cannot-be-sued-for-overcharging/
HSL19454
Nissen SE
Can We Trust Cardiovascular Practice Guidelines?
Arch Intern Med 2011 Mar 28;171:(6):584
http://archinte.ama-assn.org/cgi/content/extract/171/6/584
HSL19448
Saunders C
More proof vitamin pills do little
MJA InSight 2011 Mar 28;
http://www.mjainsight.com.au/
HSL19438
Mendelson TB, Meltzer M, Campbell EG, Caplan AL, Kirkpatrick JN
Conflicts of Interest in Cardiovascular Clinical Practice Guidelines
Arch Intern Med 2011 Mar 28;171:(6):577-584
http://archinte.ama-assn.org/cgi/content/abstract/171/6/577
HSL19429
Beasley D
Branded Drug Prices Soar as Generic Pressure Rises
Reuters 2011 Mar 28
http://www.foxbusiness.com/personal-finance/2011/03/28/branded-drug-prices-soar-generic-pressure-rises/#ixzz1Hxrd12Ie
HSL19423
Kang Lim B
China cuts maximum retail price of drugs to help tame inflation
Reuters 2011 Mar 28
http://www.reuters.com/article/2011/03/28/china-pharmaceutical-idUSL3E7ES0K920110328
HSL19422
Silverman E
The Supreme Court, Generic Labels & Preemption
Pharmalot 2011 Mar 28
http://www.pharmalot.com/2011/03/the-supreme-court-generic-labels-preemption/
HSL19421
Silverman E
Novartis, The iPad & 35,000 More Visits To Docs
Pharmalot 2011 Mar 28
http://www.pharmalot.com/2011/03/novartis-the-ipad-35000-more-visits-to-docs/
HSL19449
Kumar S, Nash DB
Health Care Myth Busters: Is There a High Degree of Scientific Certainty in Modern Medicine?
Scientific American 2011 Mar 25
http://www.scientificamerican.com/article.cfm?id=demand-better-health-care-book
HSL19464
Edwards J
Internal J&J Emails Detail 'Ugly' Chapter in Mismarketing of Antipsychotics
BNet 2011 Mar 25
http://www.bnet.com/blog/drug-business/internal-j-j-emails-detail-8220ugly-8221-chapter-in-mismarketing-of-antipsychotics/7743
HSL19424
Arnold M
One fourth of family medicine residencies pharma free says survey
Medical Marketing & Media 2011 Mar 25
http://www.mmm-online.com/one-fourth-of-family-medicine-residencies-pharma-free-says-survey/article/199268/
HSL19418
Lexchin J
Canada's Patented Medicine Notice of Compliance Regulations: Balancing the Scales or Tipping Them?
BMC Health Services Research 2011 2011 Mar 24;11:(64):
http://www.biomedcentral.com/1472-6963/11/64/abstract
HSL19411
Silverman E
Hide Side Effect Reports And Investors Can Sue
Pharmalot 2011 Mar 23
http://www.pharmalot.com/2011/03/hide-side-effect-reports-and-investors-can-sue/
HSL19459
IMS Health Launches Institute for Healthcare Informatics
IMS Health 2011 Mar 23
http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=a1e57460380ee210VgnVCM100000ed152ca2RCRD&vgnextchannel=41a67900b55a5110VgnVCM10000071812ca2RCRD&vgnextfmt=default
HSL19426
Fugh-Berman A, Brown SR, Trippett R, Bell AM, Clark P, Fleg A, Siwek J
Closing the Door on Pharma? A National Survey of Family Medicine Residencies Regarding Industry Interactions
Acad Med. 2011 Mar 23;
http://journals.lww.com/academicmedicine/Abstract/publishahead/Closing_the_Door_on_Pharma__A_National_Survey_of.99863.aspx
HSL19409
Benkimoun P
France proposes overhaul of drug regulatory system
MJA 2011 Mar 23;342:
http://www.bmj.com/content/342/bmj.d1829.extract
HSL19410
Silverman E
J&J Faces $360M Penalty Over Risperdal Marketing
Pharmalot 2011 Mar 23
http://www.pharmalot.com/2011/03/jj-faces-360m-penalty-over-risperdal-marketing/
HSL19408
Garrison L
Is America prescribing too many drugs?
wptv 2011 Mar 22
http://www.wptv.com/dpp/news/national/is-america-prescribing-too-many-drugs%3F
HSL19499
Barnett J
How Quick Response codes can help pharma engage with patients
eyeforpharma.com 2011 Mar 22
http://social.eyeforpharma.com/story/how-quick-response-codes-can-help-pharma-engage-patients
HSL19415
Silverman E
Lilly Pulls Down Strattera Web Site In China
Pharmalot 2011 Mar 21
http://www.pharmalot.com/2011/03/lilly-pulls-down-strattera-web-site-in-china/
HSL19404
Jack A
Former pharma watchdog faces restrictions
The Finanical Times 2011 Mar 21
http://www.ft.com/cms/s/0/73c0a4aa-53ce-11e0-a01c-00144feab49a.html#axzz1Hn0XT9Aj
HSL19412
Edwards J
See No Evil: How Too-Detailed Expense Reports Allegedly Got an Amgen Sales Rep Fired
BNet 2011 Mar 21
http://www.bnet.com/blog/drug-business/see-no-evil-how-too-detailed-expense-reports-allegedly-got-an-amgen-sales-rep-fired/7671
HSL19406
Branded Pharmaceutical Websites Continue to Be Most Impactful in Driving Conversions Among Prospects and Patients
Pharma Live 2011 Mar 21
http://pharmalive.com/news/index.cfm?articleID=769109
HSL19419
Jagosh J, Pluye P, Macaulay AC, Salsberg J, Henderson J, Sirett E, Bush PL, Seller R, Wong G, Greenhalgh T, Cargo M, Herbert CP, Seifer SD, Green LW
Assessing the outcomes of participatory research: protocol for identifying, selecting, appraising and synthesizing the literature for realist review
Implementation Science 2011 Mar 20;6:(1):24
http://www.implementationscience.com/content/6/1/24/abstract
HSL19433
Church S, Pettersson E
Bristol-Myers Bribed Doctors in Drug Scheme, California Commissioner Says
Bloomberg News 2011 Mar 19
http://www.bloomberg.com/news/2011-03-18/bristol-myers-bribed-doctors-in-drug-scheme-california-commissioner-says.html
HSL19416
Silverman E
California Joins Whistleblower Suit Against Bristol
Pharmalot 2011 Mar 18
http://www.pharmalot.com/2011/03/california-joins-whistleblower-suit-against-bristol/
HSL19440
Gaidos M
Hunting Ghosts
Science 2011 Mar 18
http://sciencecareers.sciencemag.org/career_magazine/previous_issues/articles/2011_03_18/caredit.a1100025
HSL19439
Silverman E
‘There Is A Louse In Your House… And Your Ad’
Pharmalot 2011 Mar 18
http://www.pharmalot.com/2011/03/there-is-a-louse-in-your-house-and-your-ad/
HSL19417
Silverman E
Senators Ask FTC To Probe KV For Price Gouging
Pharmalot 2011 Mar 18
http://www.pharmalot.com/2011/03/senators-ask-ftc-to-probe-kv-for-price-gouging/
HSL19366
Mashta O
Herbal medicines will need to be registered with drug regulator to be sold in UK
BMJ 2011 Mar 17;342:
http://www.bmj.com/content/342/bmj.d1733.extract
HSL19441
Silverman E
OxyContin, Prescribing Habits & Pharma Influence
Pharmalot 2011 Mar 17
http://www.pharmalot.com/2011/03/oxycontin-presribing-habits-pharma-influence/
HSL19413
Edwards J
How Drug Companies Look at Your Private Medical Records Any Time They Want
BNet 2011 Mar 17
http://www.bnet.com/blog/drug-business/how-drug-companies-look-at-your-private-medical-records-any-time-they-want/7653
HSL19365
Spence D
We need a Sunshine Act in the UK
BMJ 2011 Mar 16;342:
http://www.bmj.com/content/342/bmj.d1647.extract
HSL19446
Metherell M
Berocca invigorating advertising claim 'misleading'
The Sydney Morning Herald 2011 Mar 16
http://www.smh.com.au/national/berocca-invigorating-advertising-claim-misleading-20110315-1bvv2.html
HSL19443
Julious SA, Pyke S, Hughes S,
Best practice for statisticians in industry sponsored trials
BMJ 2011 Mar 15;342:
http://www.bmj.com/content/342/bmj.d1636.extract
HSL19414
Edwards J
10 Reasons Drug Prices Always Go Up — and What We Can Do About It
BNet 2011 Mar 15
http://www.bnet.com/blog/drug-business/10-reasons-drug-prices-always-go-up-8212-and-what-we-can-do-about-it/7621
HSL19342
McDonald AM, Treweek S, Shakur H, Free C, Knight R, Speed C, Campbell MK
Using a business model approach and marketing techniques for recruitment to clinical trials
Trials 2011 Mar 11;12:(1):74
http://www.trialsjournal.com/content/12/1/74
HSL19307
Silverman E
Peter Rost Takes Another Whack At Pfizer
Pharmalot 2011 Mar 11
http://www.pharmalot.com/2011/03/peter-rost-takes-another-whack-at-pfizer/
HSL19343
Cronin Fisk M, Feeley J
AstraZeneca to Pay $68.5 Million to U.S. States Over Seroquel Marketing
Bloomberg News 2011 Mar 11
http://www.bloomberg.com/news/2011-03-10/astrazeneca-to-pay-68-5-million-to-states-over-seroquel-marketing-claims.html
HSL19364
Silverman E
PR Firms, Drugmakers & Medical Societies
Pharmalot 2011 Mar 11
http://www.pharmalot.com/2011/03/pr-firms-drugmakers-medical-societies/
HSL19362
Grogan K
AstraZeneca settles Seroquel multi-state marketing probe
Pharma Times 2011 Mar 11
http://www.pharmatimes.com/Article/11-03-11/AstraZeneca_settles_Seroquel_multi-state_marketing_probe.aspx
HSL19357
Silverman E
Singing The Blues: A Merck LP & An Antidepressant
Pharmalot 2011 Mar 11
http://www.pharmalot.com/2011/03/singing-the-blues-a-merck-lp-an-antidepressant/
HSL19329
Ranjan Mishra A
Compulsory licensing norms soon
LiveMint.com 2011 Mar 10
http://www.livemint.com/2011/03/10001510/Compulsory-licensing-norms-soo.html?h=B
HSL19367
Kassirer JP
Keeping big pharma in check?
BMJ 2011 Mar 10;342:
http://www.bmj.com/content/342/bmj.d1103.extract?sid=f86e3b06-ab59-4d11-ba55-6d86ee790f12
HSL19363
Galloway G
House approves generic-drug bill meant to help poor countries
The Globe and Mail 2011 Mar 10
http://www.theglobeandmail.com/news/politics/house-approves-generic-drug-bill-meant-to-help-poor-countries/article1935976/
HSL19360
Silverman E
WHO Pandemic Moves Not Swayed By Pharma
Pharmalot 2011 Mar 10
http://www.pharmalot.com/2011/03/who-pandemic-moves-not-swayed-by-pharma/
HSL19447
Kassirer JP
Keeping big pharma in check?
BMJ 2011 Mar 10;342:
http://www.bmj.com/content/342/bmj.d1103.extract
HSL19361
Silverman E
Insider Trading, Drug Stocks & Loose-Lipped Docs
Pharmalot 2011 Mar 9
http://www.pharmalot.com/2011/03/insider-trading-drug-stocks-loose-lipped-docs/
HSL19359
Chatterjee S
Is This the End of Big Pharma?
The Motley Fool 2011 Mar 9
http://www.fool.com/investing/general/2011/03/09/is-this-the-end-of-big-pharma.aspx
Page 4 of 206 pages ‹ First < 2 3 4 5 6 > Last ›
